View PDF version
Introduced by Congressman Edward Whitfield (KY-1st) and Senator Tom Udall (NM), H.R. 1733/S. 886 would amend the Interstate Horseracing Act of 1978 to:
- Prohibit the use of performance-enhancing drugs in horses on race-day in a race subject to interstate off-track wagering.
- Creates requirements for an 'accredited third party conformity assessment body'.
- Civil penalties and suspensions from racing are laid out based on the number of violations.
- Enforcement would be carried out by the host racing commission or the Federal Trade Commission.
- There is no central agency that regulates medication use in racehorses.
- This bill is not consistent with AVMA policy on Therapeutic Medications in Racehorses.
- The AVMA and Association of Equine Practitioners support the responsible use and regulation of valid therapeutic medications in horseracing.
- The definition of performance-enhancing drugs is extremely broad and could be taken to include drugs that do not affect performance of the horse.
- There is no specific authorization of appropriations in this bill to carry out the required provisions.
- H.R. 1733: Referred to the Committee on Energy and Commerce, Subcommittee on Commerce, Manufacturing, and Trade.
- S. 886: Referred to the Committee on Commerce, Science, and Transportation.
Dr. Whitney L. Miller, Assistant Director, AVMA Governmental Relations Division, 202-289-3211.